About this trial
The aim of the study is to evaluate whether walking capacity in patients with intermittent claudication is improved more by home-based 5+ exercise training than by current recommendations of daily walking.
Eligibility criteria
Qualifiers
Pain in the calves after 300 m, or less measured on a treadmill
Stable symptoms last 6 months or more
The pain must be gone within 5 minutes after the patients stop walking
Ankle-Brachial index at 0.7 or lower at rest
Disqualifiers
pain in the hips or elsewhere outside the calves while walking
Remaining pain more than 5 minutes after stopped walking.
Impossible to compress the arteries while measruing ABI or ABI lower than 0.4
Use of statins and antiplatelet drugs less than 3 months
Trial design
Treatments tested in this trial
- Physical training
Treatment groups
Sponsors and collaborators
Norwegian University of Science and Technology
Lead sponsor
Sykehuset i Vestfold HF
Collaborator
Oslo University Hospital
Collaborator
Haukeland University Hospital
Collaborator
Sorlandet Hospital HF
Collaborator
St. Olavs Hospital
Collaborator
Sykehuset Ostfold
Collaborator
Helse Stavanger HF
Collaborator
Sykehuset Innlandet HF
Collaborator
Drammen sykehus
Collaborator
Alesund Hospital
Collaborator
Sahlgrenska University Hospital
Collaborator
Karolinska Institutet
Collaborator
University Hospital, Linkoeping
Collaborator